Check out your Company Bowl for anonymous work chats.
We are truly honored to be recognized by USA TODAY as one of the 2024 Top Workplaces in the nation! Being recognized as an "employer of choice" is a significant achievement that reflects positively on our organization's workplace culture, employee satisfaction, and overall reputation. This achievement allows us to be seen as a desirable place to work, attracting top talent, and fostering a supportive and engaging environment for our employees. It's a testament to all our efforts to create a positive and fulfilling work experience for our employees.
We're proud and honored to be named one of BioSpace's 2024 Best Places to Work for the Top 30 Small Biopharma Employers in the United States. Our placement on this list highlights our culture and the incredible people who make up Karius. Our team cares about humility, flexibility, respect, teamwork, and good judgment. Our strong company culture helps our team thrive when facing new challenges needed to push the limits of infectious disease diagnostics for the benefit of humanity. Thank you to our dedicated team for making Karius a great place to work!
Amid the rise in monkeypox cases, Alec Ford (CEO) is interviewed by several Bay Area news media stations about how metagenomic diagnostic tests such as the KariusTest provides an advantage over single pathogen PCR tests by providing an unbiased approach to testing for multiple viruses at once. https://hubs.li/Q01kxmqf0
Congratulations to all the winners! It is an honor to have been selected as the winner of the Data Team for Good Award and be among the company of those advancing the use of data to make a positive impact in the world. Per Sivan Bercovici, CTO: "Infectious disease is a public health issue extending beyond the single patient, microbes can play a broader role in human health and diseases. We are grateful for the recognition of the important work we and others are doing to bring innovative technology solutions, like Databricks, to the forefront of medicine." #DataTeamAwards #biomarker #AI
We are pleased to present new data at #ASPHO2022 from research on differentiating between #CytokineReleaseSyndrome and #infections in patients who received #CARTcelltherapy and on invasive #fungal infections in children with leukemia. Visit us at booth 300. #liquidbiopsy #cellfreeDNA.
Listen to Sivan Bercovici, our CTO, discuss how Karius is using #AI to advance infectious disease diagnostics by using a novel data type, microbial cell-free DNA. We're also #hiring talented data scientists and computational biologists! Join us in pioneering this new field in medicine. #mcfDNA #cfDNA #machinelearning
The Karius Mobile App is officially a Gold Winner at the AVA Awards in the Creativity Web Design Category! We're so proud of the work everyone has put into making this app for clinicians successful. See how our app works here: https://hubs.li/Q015pzs-0
To make it easier than ever for clinicians to quickly access results and bring #digitalhealth to #infectiousdisease, we've launched the Karius Mobile App. Take a look at how it works here: https://hubs.li/Q0140pHH0
For those battling cancer, infections can be more deadly than the underlying malignancy. Our CEO Alec Ford joined Authority Magazine to share the 5 things to know about cancer and infections.
We're proud to announce that the Karius Test is the inaugural winner for the Infectious Disease Testing Solution of the Year in the BioTech Breakthrough Awards! This is a great honor!
